Key considerations for patent counsel when evaluating potential conflicts of interest, including identifying conflicts between current and former clients, understanding relevant authority, navigating ...
Atossa is also announcing the issuance of a new patent on January 21, 2025, U.S. Patent No. 12,201,591, entitled, “Sustained Release Compositions of Endoxifen.” The 31 claims of this new patent are ...